138 results on '"Sabidó E"'
Search Results
2. UNRAVELLING BRCA1-DEPENDENT MOLECULAR MECHANISMS IN OVARIAN CANCER BY MULTI-LEVEL PROTEOMICS: EP1117
- Author
-
Bradbury, M, Borràs, E., Pérez-Benavente, A, De la Torre, J, Gil-Moreno, A, Sabidó, E, and Santamaria, A
- Published
- 2019
- Full Text
- View/download PDF
3. 873 Pap-smears allow the identification of protein biomarkers to diagnose endometrial cancer
- Author
-
Cabrera, S, primary, Coll-de la Rubia, E, additional, Martínez Garcia, E, additional, Lesur, A, additional, Reques, A, additional, Casares de Cal, MA, additional, Gomez Tato, A, additional, Sabidó, E, additional, Borrás, E, additional, Peiró, R, additional, Dittmar, G, additional, Gil-Moreno, A, additional, and Colas, E, additional
- Published
- 2021
- Full Text
- View/download PDF
4. Multi-omics signatures of the human early life exposome
- Author
-
Mark J. Nieuwenhuijsen, Hector C. Keun, John Wright, L. Chatzi, González, Tamayo I, Gallego-Paüls M, Sandra Andrusaityte, Inés Quintela, Léa Maitre, Eva Borràs, Dan Mason, Amrit Kaur Sakhi, Jordi Sunyer, Marta Vives-Usano, Barbara Heude, Muireann Coen, Solène Cadiou, Chung-Ho E Lau, Sabidó E, Denise Thiel, Xavier Estivill, Angel Carracedo, Jose Urquiza, Eleni Papadopoulou, Martine Vrijheid, Regina Grazuleviciene, Casas M, Kristine B. Gutzkow, Carles Hernandez-Ferrer, Rémy Slama, Alexandros P. Siskos, Carlos Ruiz-Arenas, Mariona Bustamante, Cathrine Thomsen, Marina Vafeiadi, and Oliver Robinson
- Subjects
Exposome ,Pregnancy ,Environmental health ,Maternal smoking ,Metabolome ,medicine ,Multi omics ,Biology ,Omics ,medicine.disease ,Early life - Abstract
SummaryEnvironmental exposures during early life play a critical role in life-course health, yet the molecular phenotypes underlying environmental effects on health are poorly understood. In the Human Early Life Exposome (HELIX) project, a multi-centre cohort of 1,301 mother-child pairs, we associated individual exposomes consisting of >100 chemical, physical and lifestyle exposures assessed in pregnancy and childhood, with multi-omics profiles (methylome, transcriptome, metabolome and proteins) in childhood. We identified 1,170 associations, 249 in pregnancy and 921 in childhood, which revealed potential biological responses and sources of exposure. The methylome best captures the persistent influence of pregnancy exposures, including maternal smoking; while childhood exposures were associated with features from all omics layers, revealing novel signatures for indoor air quality, essential trace elements, endocrine disruptors and weather conditions. This study provides a unique resource (https://helixomics.isglobal.org/) to guide future investigation on the biological effects of the early life exposome.
- Published
- 2021
- Full Text
- View/download PDF
5. Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity
- Author
-
Tristán-Noguero, A. Borràs, E. Molero-Luis, M. Wassenberg, T. Peters, T. Verbeek, M.M. Willemsen, M. Opladen, T. Jeltsch, K. Pons, R. Thony, B. Horvath, G. Yapici, Z. Friedman, J. Hyland, K. Agosta, G.E. López-Laso, E. Artuch, R. Sabidó, E. García-Cazorla, À.
- Abstract
Background: Genetic defects of monoamine neurotransmitters are rare neurological diseases amenable to treatment with variable response. They are major causes of early parkinsonism and other spectrum of movement disorders including dopa-responsive dystonia. Objectives: The objective of this study was to conduct proteomic studies in cerebrospinal fluid (CSF) samples of patients with monoamine defects to detect biomarkers involved in pathophysiology, clinical phenotypes, and treatment response. Methods: A total of 90 patients from diverse centers of the International Working Group on Neurotransmitter Related Disorders were included in the study (37 untreated before CSF collection, 48 treated and 5 unknown at the collection time). Clinical and molecular metadata were related to the protein abundances in the CSF. Results: Concentrations of 4 proteins were significantly altered, detected by mass spectrometry, and confirmed by immunoassays. First, decreased levels of apolipoprotein D were found in severe cases of aromatic L-amino acid decarboxylase deficiency. Second, low levels of apolipoprotein H were observed in patients with the severe phenotype of tyrosine hydroxylase deficiency, whereas increased concentrations of oligodendrocyte myelin glycoprotein were found in the same subset of patients with tyrosine hydroxylase deficiency. Third, decreased levels of collagen6A3 were observed in treated patients with tetrahydrobiopterin deficiency. Conclusion: This study with the largest cohort of patients with monoamine defects studied so far reports the proteomic characterization of CSF and identifies 4 novel biomarkers that bring new insights into the consequences of early dopaminergic deprivation in the developing brain. They open new possibilities to understand their role in the pathophysiology of these disorders, and they may serve as potential predictors of disease severity and therapies. © 2020 International Parkinson and Movement Disorder Society. © 2020 International Parkinson and Movement Disorder Society
- Published
- 2021
6. Genome-wide postnatal changes in immunity following fetal inflammatory response
- Author
-
Costa D, Bonet N, Solé A, González de Aledo-Castillo JM, Sabidó E, Casals F, Rovira-Zurriaga C, Nadal A, Luis Marin J, Cobo T, and Castelo R
- Subjects
transcriptomics ,proteomics ,postnatal immunity ,fetal inflammatory response ,preterm birth - Abstract
The fetal inflammatory response (FIR) increases the risk of perinatal brain injury, particularly in extremely low gestational age newborns (ELGANs
- Published
- 2021
7. Ecto-GPR37:a potential biomarker for Parkinson’s disease
- Author
-
Morató, X. (Xavier), Garcia-Esparcia, P. (Paula), Argerich, J. (Josep), Llorens, F. (Franc), Zerr, I. (Inga), Paslawski, W. (Wojciech), Borràs, E. (Eva), Sabidó, E. (Eduard), Petäjä-Repo, U. E. (Ulla E.), Fernández-Dueñas, V. (Víctor), Ferrer, I. (Isidro), Svenningsson, P. (Per), Ciruela, F. (Francisco), Morató, X. (Xavier), Garcia-Esparcia, P. (Paula), Argerich, J. (Josep), Llorens, F. (Franc), Zerr, I. (Inga), Paslawski, W. (Wojciech), Borràs, E. (Eva), Sabidó, E. (Eduard), Petäjä-Repo, U. E. (Ulla E.), Fernández-Dueñas, V. (Víctor), Ferrer, I. (Isidro), Svenningsson, P. (Per), and Ciruela, F. (Francisco)
- Abstract
Objective: α-Synuclein has been studied as a potential biomarker for Parkinson’s disease (PD) with no concluding results. Accordingly, there is an urgent need to find out reliable specific biomarkers for PD. GPR37 is an orphan G protein-coupled receptor that toxically accumulates in autosomal recessive juvenile parkinsonism. Here, we investigated whether GPR37 is upregulated in sporadic PD, and thus a suitable potential biomarker for PD. Methods: GPR37 protein density and mRNA expression in postmortem substantia nigra (SN) from PD patients were analysed by immunoblot and RT-qPCR, respectively. The presence of peptides from the N-terminus-cleaved domain of GPR37 (i.e. ecto-GPR37) in human cerebrospinal fluid (CSF) was determined by liquid chromatography-mass spectrometric analysis. An engineered in-house nanoluciferase-based immunoassay was used to quantify ecto-GPR37 in CSF samples from neurological control (NC) subjects, PD patients and Alzheimer’s disease (AD) patients. Results: GPR37 protein density and mRNA expression were significantly augmented in sporadic PD. Increased amounts of ecto-GPR37 peptides in the CSF samples from PD patients were identified by mass spectrometry and quantified by the in-house ELISA method. However, the CSF total α-synuclein level in PD patients did not differ from that in NC subjects. Similarly, the cortical GPR37 mRNA expression and CSF ecto-GPR37 levels in AD patients were also unaltered. Conclusions: GPR37 expression is increased in SN of sporadic PD patients. The ecto-GPR37 peptides are significantly increased in the CSF of PD patients, but not in AD patients. These results open perspectives and encourage further clinical studies to confirm the validity and utility of ecto-GPR37 as a potential PD biomarker.
- Published
- 2021
8. Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity
- Author
-
Tristán-Noguero, A., Borràs, E., Molero-Luis, M., Wassenberg, T., Peters, T.M.A., Verbeek, M.M., Willemsen, M.A., Opladen, T., Jeltsch, K., Pons, R., Thony, B., Horvath, G., Yapici, Z., Friedman, J., Hyland, K., Agosta, G.E., López-Laso, E., Artuch, R., Sabidó, E., García-Cazorla, À., Tristán-Noguero, A., Borràs, E., Molero-Luis, M., Wassenberg, T., Peters, T.M.A., Verbeek, M.M., Willemsen, M.A., Opladen, T., Jeltsch, K., Pons, R., Thony, B., Horvath, G., Yapici, Z., Friedman, J., Hyland, K., Agosta, G.E., López-Laso, E., Artuch, R., Sabidó, E., and García-Cazorla, À.
- Abstract
Item does not contain fulltext
- Published
- 2021
9. Molecular signature of cardiogenic shock
- Author
-
Iborra-Egea O, Rueda F, García-García C, Borràs E, Sabidó E, and Bayes-Genis A
- Subjects
Cardiogenic shock, Genome, Molecular, Proteome, Transcriptome - Abstract
The incidence of cardiogenic shock (CS) has increased remarkably over the past decade and remains a challenging condition with mortality rates of ~50%. Cardiogenic shock encompasses cardiac contractile dysfunction; however, it is also a multiorgan dysfunction syndrome, often complicated by a systemic inflammatory response with severe cellular and metabolic dysregulations. Here, we review the evidence on the biochemical manifestations of CS, elaborating on current gold standard biomarkers and novel candidates from molecular signatures of CS. Glucose and lactate, both identified over a century ago, remain the only clinically used biomarkers in current predictive risk scores. Novel genomic, transcriptomic, and proteomic data are discussed, and a recently reported molecular score derived from unbiased proteomic discovery, the CS4P, which includes liver fatty acid-binding protein, beta-2-microglobulin, fructose-bisphosphate aldolase B, and SerpinG1 is comprehensively described. Recent advances in -omics technologies provide new insight into a more holistic molecular signature of CS. Thus, we need to open new diagnostic and therapeutic avenues if we aim to improve outcomes.
- Published
- 2020
10. Association of fish consumption and mercury exposure during pregnancy with metabolic health and inflammatory biomarkers in children
- Author
-
John Wright, Martine Vrijheid, Juan R. González, Nikos Stratakis, Eva Borràs, Eleni Papadopoulou, Xavier Basagaña, Serena Fossati, Rob McConnell, David V. Conti, Mariona Bustamante, Rosemary R. C. McEachan, Barbara Heude, Sabidó E, Lydiane Agier, Jane West, Marina Vafeiadi, Jose Urquiza, Leda Chatzi, Helle Margrete Meltzer, Ioannis Theologidis, Léa Maitre, Maribel Casas, Regina Grazuleviciene, Anne Lise Brantsæter, Theano Roumeliotaki, Shohreh F. Farzan, RS: NUTRIM - R3 - Respiratory & Age-related Health, and Complexe Genetica
- Subjects
Infants -- Malalties ,Embaràs ,CHILDHOOD ,CONSUMERS ,BLOOD-PRESSURE ,DISEASE ,0302 clinical medicine ,Pregnancy ,Risk Factors ,Prospective Studies ,030212 general & internal medicine ,Child ,Original Investigation ,2. Zero hunger ,RISK ,0303 health sciences ,education.field_of_study ,INSULIN-RESISTANCE ,ROLES ,Obstetrics ,Incidence ,Fishes ,General Medicine ,PRENATAL METHYLMERCURY EXPOSURE ,3. Good health ,Online Only ,Maternal Exposure ,Prenatal Exposure Delayed Effects ,Cohort ,Female ,Adult ,medicine.medical_specialty ,Waist ,Offspring ,Population ,03 medical and health sciences ,Insulin resistance ,medicine ,Animals ,Humans ,Mercuri -- Toxicologia ,education ,030304 developmental biology ,Inflammation ,business.industry ,Research ,Nutrition, Obesity, and Exercise ,Mercury ,medicine.disease ,United States ,Blood pressure ,Mercury Poisoning ,Peix ,Metabolic syndrome ,business ,Biomarkers - Abstract
Key Points Question Is fish consumption during pregnancy associated with benefits for the metabolic health of children? Findings In this cohort study of 805 mothers and their singleton offspring, moderate fish consumption during pregnancy was associated with the downregulation of inflammation and improvements in the metabolic profile of children; high mercury exposure during pregnancy had the opposite associations. Meaning The results of this study suggest that fish consumption consistent with current recommendations during pregnancy was associated with improvements in the metabolic health of children., Importance The balance of mercury risk and nutritional benefit from fish intake during pregnancy for the metabolic health of offspring to date is unknown. Objective To assess the associations of fish intake and mercury exposure during pregnancy with metabolic syndrome in children and alterations in biomarkers of inflammation in children. Design, Setting, and Participants This population-based prospective birth cohort study used data from studies performed in 5 European countries (France, Greece, Norway, Spain, and the UK) between April 1, 2003, and February 26, 2016, as part of the Human Early Life Exposome (HELIX) project. Mothers and their singleton offspring were followed up until the children were aged 6 to 12 years. Data were analyzed between March 1 and August 2, 2019. Exposures Maternal fish intake during pregnancy (measured in times per week) was assessed using validated food frequency questionnaires, and maternal mercury concentration (measured in micrograms per liter) was assessed using maternal whole blood and cord blood samples. Main Outcomes and Measures An aggregate metabolic syndrome score for children was calculated using the z scores of waist circumference, systolic and diastolic blood pressures, and levels of triglyceride, high-density lipoprotein cholesterol, and insulin. A higher metabolic syndrome score (score range, −4.9 to 7.5) indicated a poorer metabolic profile. Three protein panels were used to measure several cytokines and adipokines in the plasma of children. Results The study included 805 mothers and their singleton children. Among mothers, the mean (SD) age at cohort inclusion or delivery of their infant was 31.3 (4.6) years. A total of 400 women (49.7%) had a high educational level, and 432 women (53.7%) were multiparous. Among children, the mean (SD) age was 8.4 (1.5) years (age range, 6-12 years). A total of 453 children (56.3%) were boys, and 734 children (91.2%) were of white race/ethnicity. Fish intake consistent with health recommendations (1 to 3 times per week) during pregnancy was associated with a 1-U decrease in metabolic syndrome score in children (β = −0.96; 95% CI, −1.49 to −0.42) compared with low fish consumption (, This cohort study used data from the Human Early Life Exposome (HELIX) project, a collaboration of 5 European birth cohort studies, to examine the associations of maternal fish consumption and mercury exposure during pregnancy with metabolic health and inflammatory biomarkers in children.
- Published
- 2020
11. Re-establishment of the epigenetic state and rescue of kinome deregulation in Ts65Dn mice upon treatment with green tea extract and environmental enrichment
- Author
-
Mara Dierssen, Cesar Sierra, I. De Toma, Sabidó E, Silvina Catuara-Solarz, and Mireia Ortega
- Subjects
Proteomics ,Transgene ,lcsh:Medicine ,Mice, Transgenic ,Green tea extract ,Biology ,Hippocampus ,Camellia sinensis ,Catechin ,Article ,Epigenesis, Genetic ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Cognition ,Tandem Mass Spectrometry ,Animals ,Kinome ,Epigenetics ,Protein Interaction Maps ,Kinase activity ,Phosphorylation ,lcsh:Science ,030304 developmental biology ,0303 health sciences ,Environmental enrichment ,Multidisciplinary ,Plant Extracts ,lcsh:R ,Developmental disorders ,3. Good health ,Chromatin ,Cell biology ,Disease Models, Animal ,Proteome ,Diseases of the nervous system ,lcsh:Q ,Down Syndrome ,030217 neurology & neurosurgery ,Chromatography, Liquid - Abstract
Down syndrome (DS) is the main genetic cause of intellectual disability due to triplication of human chromosome 21 (HSA21). Although there is no treatment for intellectual disability, environmental enrichment (EE) and the administration of green tea extracts containing epigallocatechin-3-gallate (EGCG) improve cognition in mouse models and individuals with DS. Using proteome, and phosphoproteome analysis in the hippocampi of a DS mouse model (Ts65Dn), we investigated the possible mechanisms underlying the effects of green tea extracts, EE and their combination. Our results revealed disturbances in cognitive-related (synaptic proteins, neuronal projection, neuron development, microtubule), GTPase/kinase activity and chromatin proteins. Green tea extracts, EE, and their combination restored more than 70% of the phosphoprotein deregulation in Ts65Dn, and induced possible compensatory effects. Our downstream analyses indicate that re-establishment of a proper epigenetic state and rescue of the kinome deregulation may contribute to the cognitive rescue induced by green tea extracts. This work was supported by the Fondation Jérôme Lejeune Foundation (Project #1347 “Elucidation of the mechanism of action of epigallocatechin-3-gallate as a therapeutic agent on the cognitive phenotype in Down Syndrome mice models”), Agencia Estatal de Investigación (AEI) (PID2019-110755RB-I00/AEI/10.13039/501100011033), H2020 SC1 Gene overdosage and comorbidities during the early lifetime in Down Syndrome GO-DS21-848077, Fundació La Marató De TV3 (201620-31_MDierssen), EU (JPND HEROES (tHE cRossroad Of dEmentia Syndromes), NIH (Grant Number: 1R01EB 028159-01). The CRG is a Center of Excellence Severo Ochoa. The CIBER of Rare Diseases is an initiative of the ISCIII. The laboratories of M. Dierssen and E. Sabidó are supported by DIUE de la Generalitat de Catalunya (Grups consolidats 2017SGR926, 2017SGR595). The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17/0019 of the PE I+D+i 2013-2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF. We also acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya.
- Published
- 2020
- Full Text
- View/download PDF
12. The dental proteome of Homo antecessor
- Author
-
Universitat Rovira i Virgili, Welker F; Ramos-Madrigal J; Gutenbrunner P; Mackie M; Tiwary S; Rakownikow Jersie-Christensen R; Chiva C; Dickinson MR; Kuhlwilm M; de Manuel M; Gelabert P; Martinón-Torres M; Margvelashvili A; Arsuaga JL; Carbonell E; Marques-Bonet T; Penkman K; Sabidó E; Cox J; Olsen JV; Lordkipanidze D; Racimo F; Lalueza-Fox C; Bermúdez de Castro JM; Willerslev E; Cappellini E, Universitat Rovira i Virgili, and Welker F; Ramos-Madrigal J; Gutenbrunner P; Mackie M; Tiwary S; Rakownikow Jersie-Christensen R; Chiva C; Dickinson MR; Kuhlwilm M; de Manuel M; Gelabert P; Martinón-Torres M; Margvelashvili A; Arsuaga JL; Carbonell E; Marques-Bonet T; Penkman K; Sabidó E; Cox J; Olsen JV; Lordkipanidze D; Racimo F; Lalueza-Fox C; Bermúdez de Castro JM; Willerslev E; Cappellini E
- Abstract
© 2020, The Author(s), under exclusive licence to Springer Nature Limited. The phylogenetic relationships between hominins of the Early Pleistocene epoch in Eurasia, such as Homo antecessor, and hominins that appear later in the fossil record during the Middle Pleistocene epoch, such as Homo sapiens, are highly debated1–5. For the oldest remains, the molecular study of these relationships is hindered by the degradation of ancient DNA. However, recent research has demonstrated that the analysis of ancient proteins can address this challenge6–8. Here we present the dental enamel proteomes of H. antecessor from Atapuerca (Spain)9,10 and Homo erectus from Dmanisi (Georgia)1, two key fossil assemblages that have a central role in models of Pleistocene hominin morphology, dispersal and divergence. We provide evidence that H. antecessor is a close sister lineage to subsequent Middle and Late Pleistocene hominins, including modern humans, Neanderthals and Denisovans. This placement implies that the modern-like face of H. antecessor—that is, similar to that of modern humans—may have a considerably deep ancestry in the genus Homo, and that the cranial morphology of Neanderthals represents a derived form. By recovering AMELY-specific peptide sequences, we also conclude that the H. antecessor molar fragment from Atapuerca that we analysed belonged to a male individual. Finally, these H. antecessor and H. erectus fossils preserve evidence of enamel proteome phosphorylation and proteolytic digestion that occurred in vivo during tooth formation. Our results provide important insights into the evolutionary relationships between H. antecessor and other hominin groups, and pave the way for future studies using enamel proteomes to investigate hominin biology across the existence of the ge
- Published
- 2020
13. EP1117 Unravelling BRCA1-dependent molecular mechanisms in ovarian cancer by multi-level proteomics
- Author
-
Bradbury, M, primary, Borràs, E., additional, Pérez-Benavente, A, additional, De la Torre, J, additional, Gil-Moreno, A, additional, Sabidó, E, additional, and Santamaria, A, additional
- Published
- 2019
- Full Text
- View/download PDF
14. Characterization of cholesteryl ester-loaded human coronary vascular smooth muscle cell secretome. A source of potential biomarkers of coronary artery disease
- Author
-
Rodríguez, J.E.G., Amaro, A. Benitez, Claudi, L., Ni, J., Pallara, C., Prades, R., Tarrago, T., Espadas-Garcia, G., Sabido, E., and Llorente-Cortés, V.
- Published
- 2021
- Full Text
- View/download PDF
15. Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer
- Author
-
Sequeiros T, Rigau M, Chiva C, Montes M, Garcia-Grau I, Garcia-López M, Diaz S, Celma A, Bijnsdorp I, Campos A, Di Mauro P, Borrós S, Reventós J, Doll A, Paciucci R, Pegtel M, de Torres I, Sabidó E, Morote J, and Olivan M
- Published
- 2017
16. Fish consumption during pregnancy, exposure to mercury, and child metabolic syndrome
- Author
-
Léa Maitre, John Wright, L. Chatzi, Rémy Slama, Thomsen C, Martine Vrijheid, Sabidó E, Nikos Stratakis, David V. Conti, and Eleni Papadopoulou
- Subjects
Global and Planetary Change ,Pregnancy ,Epidemiology ,business.industry ,Health, Toxicology and Mutagenesis ,Public Health, Environmental and Occupational Health ,Physiology ,chemistry.chemical_element ,medicine.disease ,Fish consumption ,Pollution ,Mercury (element) ,chemistry ,medicine ,Metabolic syndrome ,business - Published
- 2019
- Full Text
- View/download PDF
17. Proteomics of triple negative breast cancer developing metastases to central nervous system
- Author
-
Rojas, K., primary, Trilla-Fuertes, L., additional, Gámez, A., additional, Sepulveda Sanchez, J., additional, Manso Sánchez, L., additional, Prado-Vásquez, G., additional, Chiva, C., additional, Zapater-Moros, A., additional, Llorente-Armijo, S., additional, Mendiola, D.C., additional, Sabidó, E., additional, Fresno, J.A., additional, Ciruelos Gil, E.M., additional, and Paz-Ares, L., additional
- Published
- 2017
- Full Text
- View/download PDF
18. Network-based proteomic approaches reveal the neurodegenerative, neuroprotective and pain-related mechanisms involved after retrograde axonal damage
- Author
-
Joaquim Forés, Patrick Aloy, Mireia Herrando-Grabulosa, Francesco M. Mancuso, Sabidó E, Eva Borràs, Laura Isus, and Caty Casas
- Subjects
Male ,Proteomics ,medicine.medical_treatment ,Pain ,Endogeny ,Biology ,Neuroprotection ,Article ,Rats, Sprague-Dawley ,Retrograde Degeneration ,medicine ,Animals ,Anoikis ,Protein Interaction Maps ,Motor Neurons ,Multidisciplinary ,Axotomy ,Neurodegenerative Diseases ,Regenerative process ,Axons ,Rats ,medicine.anatomical_structure ,Soma ,Disconnection ,Neurogenètica ,Neuroscience ,Proteïnes - Abstract
We thank to Ghyzlane El Korchi for excellent technical help and to Marta Morell for taking tremendous good care of the animals. This work was supported by grants from Fundació La marató-TV3 (#110432) who was funding all the present work and the postdoctoral fellowship of MHG. This work was partially supported by the European commission through the SyStemAge project (Agreement no: 306240). LI is a recipient of a PhD La Caixa fellowship. Altres ajuts: Fundació La marató-TV3 (ajut núm. 110432) Neurodegenerative processes are preceded by neuronal dysfunction and synaptic disconnection. Disconnection between spinal motoneuron (MN) soma and synaptic target leads either to a retrograde degenerative process or to a regenerative reaction, depending injury proximity among other factors. Distinguished key events associated with one or other processes may give some clues towards new therapeutical approaches based on boosting endogenous neuroprotective mechanisms. Root mechanical traction leads to retrograde MN degeneration, but share common initial molecular mechanisms with a regenerative process triggered by distal axotomy and suture. By 7 days post-injury, key molecular events starts to diverge and sign apart each destiny. We used comparative unbiased proteomics to define these signatures, coupled to a novel network-based analysis to get biological meaning. The procedure implicated the previous generation of combined topological information from manual curated 19 associated biological processes to be contrasted with the proteomic list using gene enrichment analysis tools. The novel and unexpected results suggested that motoneurodegeneration is better explained mainly by the concomitant triggering of anoikis, anti-apoptotic and neuropathic-pain related programs. In contrast, the endogenous neuroprotective mechanisms engaged after distal axotomy included specifically rather anti-anoikis and selective autophagy. Validated protein-nodes and processes are highlighted across discussion.
- Published
- 2014
19. Chemically synthesized peptide libraries as a new source of BBB shuttles. Use of mass spectrometry for peptide identification
- Author
-
Guixer, B., primary, Arroyo, X., additional, Belda, I., additional, Sabidó, E., additional, Teixidó, M., additional, and Giralt, E., additional
- Published
- 2016
- Full Text
- View/download PDF
20. PO-049 Quantitative proteomics unveils key mitotic regulators involved in the transition to androgen independent prostate cancer
- Author
-
Masia, N., Olivan, M., Paciucci, R., Morote, J., Gil-Moreno, A., Borras, E., Sabido, E., and Santamaria, A.
- Published
- 2018
- Full Text
- View/download PDF
21. 1696P - Proteomics of triple negative breast cancer developing metastases to central nervous system
- Author
-
Rojas, K., Trilla-Fuertes, L., Gámez, A., Sepulveda Sanchez, J., Manso Sánchez, L., Prado-Vásquez, G., Chiva, C., Zapater-Moros, A., Llorente-Armijo, S., Mendiola, D.C., Sabidó, E., Fresno, J.A., Ciruelos Gil, E.M., and Paz-Ares, L.
- Published
- 2017
- Full Text
- View/download PDF
22. all-D proline-rich cell-penetrating peptides: a preliminary in vivo internalization study
- Author
-
Pujals, S., primary, Sabidó, E., additional, Tarragó, T., additional, and Giralt, E., additional
- Published
- 2007
- Full Text
- View/download PDF
23. A combination of molecular and clinical parameters provides a new strategy for high-grade serous ovarian cancer patient management
- Author
-
Melissa Bradbury, Eva Borràs, Marta Vilar, Josep Castellví, José Luis Sánchez-Iglesias, Assumpció Pérez-Benavente, Antonio Gil-Moreno, Anna Santamaria, Eduard Sabidó, Institut Català de la Salut, [Bradbury M] Centre de Regulació Genòmica, Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. Universitat Pompeu Fabra, Barcelona, Spain. Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Borràs E, Sabidó E] Centre de Regulació Genòmica, Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. Universitat Pompeu Fabra, Barcelona, Spain. [Vilar M] Centre de Regulació Genòmica, Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Castellví J] Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Sánchez-Iglesias JL, Pérez-Benavente A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Gil-Moreno A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. [Santamaria A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Laboratori de Cicle Cel·lular i Càncer, Grup de Recerca Biomèdica en Urologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
Proteomics ,Ovarian Neoplasms ,Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Ovarian Neoplasms [DISEASES] ,Marcadors tumorals ,Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores] ,factores biológicos::biomarcadores::marcadores tumorales [COMPUESTOS QUÍMICOS Y DROGAS] ,Proteins ,General Medicine ,Ovaris - Càncer - Tractament ,neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias ováricas [ENFERMEDADES] ,Other subheadings::Other subheadings::/drug therapy [Other subheadings] ,General Biochemistry, Genetics and Molecular Biology ,Cystadenocarcinoma, Serous ,Neoplasms::Neoplasms by Histologic Type::Neoplasms, Glandular and Epithelial::Carcinoma::Adenocarcinoma::Cystadenocarcinoma::Cystadenocarcinoma, Serous [DISEASES] ,Biomarkers, Tumor ,Humans ,Female ,Biological Factors::Biomarkers::Biomarkers, Tumor [CHEMICALS AND DRUGS] ,neoplasias::neoplasias por tipo histológico::neoplasias glandulares y epiteliales::carcinoma::adenocarcinoma::cistoadenocarcinoma::cistoadenocarcinoma seroso [ENFERMEDADES] - Abstract
Biomarker; Prediction; Proteomics Biomarcador; Predicción; Proteómica Biomarcador; Predicció; Proteòmica Background High-grade serous carcinoma (HGSC) is the most common and deadly subtype of ovarian cancer. Although most patients will initially respond to first-line treatment with a combination of surgery and platinum-based chemotherapy, up to a quarter will be resistant to treatment. We aimed to identify a new strategy to improve HGSC patient management at the time of cancer diagnosis (HGSC-1LTR). Methods A total of 109 ready-available formalin-fixed paraffin-embedded HGSC tissues obtained at the time of HGSC diagnosis were selected for proteomic analysis. Clinical data, treatment approach and outcomes were collected for all patients. An initial discovery cohort (n = 21) were divided into chemoresistant and chemosensitive groups and evaluated using discovery mass-spectrometry (MS)-based proteomics. Proteins showing differential abundance between groups were verified in a verification cohort (n = 88) using targeted MS-based proteomics. A logistic regression model was used to select those proteins able to correctly classify patients into chemoresistant and chemosensitive. The classification performance of the protein and clinical data combinations were assessed through the generation of receiver operating characteristic (ROC) curves. Results Using the HGSC-1LTR strategy we have identified a molecular signature (TKT, LAMC1 and FUCO) that combined with ready available clinical data (patients’ age, menopausal status, serum CA125 levels, and treatment approach) is able to predict patient response to first-line treatment with an AUC: 0.82 (95% CI 0.72–0.92). Conclusions We have established a new strategy that combines molecular and clinical parameters to predict the response to first-line treatment in HGSC patients (HGSC-1LTR). This strategy can allow the identification of chemoresistance at the time of diagnosis providing the optimization of therapeutic decision making and the evaluation of alternative treatment strategies. Thus, advancing towards the improvement of patient outcome and the individualization of HGSC patients’ care. This work was supported by the PhD4MD collaborative research program between the Vall d’Hebron Research Institute (VHIR) and the Centre for Genomic Regulation (CRG). It has been supported by grants from the Instituto Carlos III (PI18/01017), the Miguel Servet Program (CPII18/00027) and the Ministerio de Economía y Competitividad y Fondos FEDER (RTC-2015-3821-1 to AS and CTQ2016-80364-P to ES). This project has also received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 823839 (EPIC-XS).The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is supported by “Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya” (2017SGR595 and 2017SGR1661). We also acknowledge support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme / Generalitat de Catalunya.
- Published
- 2022
24. BRCA1 mutations in high-grade serous ovarian cancer are associated with proteomic changes in DNA repair, splicing, transcription regulation and signaling
- Author
-
Bradbury, Melissa, Castellvi, Josep, Méndez Fernández, Olga, Sanchez Iglesias, Jose Luis, Pérez-Benavente, Assumpció, Gil-Moreno, Antonio, Sabidó, Eduard, Santamaría, Anna, Borràs, Eva, Universitat Autònoma de Barcelona. Vall d'Hebron Institut de Recerca (VHIR), Institut Català de la Salut, [Bradbury M] Proteomics Unit, Centre de Regulació Genòmica, Barcelona Institute of Science and Technology (BIST), 08003 Barcelona, Spain. Universitat Pompeu Fabra, 08003 Barcelona, Spain. Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Borràs E, Sabidó E] Proteomics Unit, Centre de Regulació Genòmica, Barcelona Institute of Science and Technology (BIST), 08003 Barcelona, Spain. Universitat Pompeu Fabra, 08003 Barcelona, Spain. [Castellví J] Servei de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Méndez O] Laboratori de Cicle Cel•lular i Càncer, Grup de Recerca Biomèdica en Urologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Sánchez-Iglesias JL, Pérez-Benavente A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Gil-Moreno A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain. [Santamaria A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Laboratori de Cicle Cel•lular i Càncer, Grup de Recerca Biomèdica en Urologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
Ovarian Neoplasms ,Proteomics ,ADN - Reparació ,Multidisciplinary ,Genetic Phenomena::DNA Repair [PHENOMENA AND PROCESSES] ,DNA Repair ,BRCA1 Protein ,Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Ovarian Neoplasms [DISEASES] ,Mutació (Biologia) ,Genetic Phenomena::Genetic Variation::Mutation [PHENOMENA AND PROCESSES] ,neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias ováricas [ENFERMEDADES] ,Ovaris -- Càncer ,fenómenos genéticos::reparación del ADN [FENÓMENOS Y PROCESOS] ,Cystadenocarcinoma, Serous ,Genòmica ,Ovaris - Càncer ,Ovarian cancer ,Mutation ,Humans ,Female ,fenómenos genéticos::variación genética::mutación [FENÓMENOS Y PROCESOS] ,Genètica - Abstract
Ovarian cancer; Proteomics Cáncer de ovarios: Proteómica Càncer d'ovaris; Proteòmica Despite recent advances in the management of BRCA1 mutated high-grade serous ovarian cancer (HGSC), the physiology of these tumors remains poorly understood. Here we provide a comprehensive molecular understanding of the signaling processes that drive HGSC pathogenesis with the addition of valuable ubiquitination profiling, and their dependency on BRCA1 mutation-state directly in patient-derived tissues. Using a multilayered proteomic approach, we show the tight coordination between the ubiquitination and phosphorylation regulatory layers and their role in key cellular processes related to BRCA1-dependent HGSC pathogenesis. In addition, we identify key bridging proteins, kinase activity, and post-translational modifications responsible for molding distinct cancer phenotypes, thus providing new opportunities for therapeutic intervention, and ultimately advance towards a more personalized patient care. This work was supported by the PhD4MD collaborative research program between the Vall d’Hebron Research Institute (VHIR) and the Centre for Genomic Regulation (CRG). The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17/0019 of the PE I+D+i 2013-2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF. We acknowledge support from the Spanish Ministry of Science, Innovation and Universities, (CTQ2016-80364-P and “Centro de Excelencia Severo Ochoa 2013-2017”, SEV-2012-0208), and “Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya” (2017SGR595 and 2017SGR1661). This project has also received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No 823839 (EPIC-XS). It has also been supported by grants from the Instituto Carlos III (PI15/00238, PI18/01017, PI21/00977), the Miguel Servet Program (CP13/00158 and CPII18/00027) and the Ministerio de Economía y Competitividad y Fondos FEDER (RTC-2015-3821-1). The authors are grateful to the team members of the Proteomics Unit at the Centre for Genomic Regulation, the Biomedical Research Group in Gynecology at the Vall d’Hebron Institute, the Gynecological Oncology Unit at the Vall d’Hebron Hospital and the Biomedical Research Group in Urology at the Vall d’Hebron Institute for their assistance.
- Published
- 2022
25. Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients: A Mini-Review
- Author
-
Anna Santamaria, Assumpció Pérez-Benavente, Eduard Sabidó, Antonio Gil-Moreno, Melissa Bradbury, Eva Borràs, Institut Català de la Salut, [Bradbury M] Centre de Regulació Genòmica, Barcelona Institute of Science and Technology (BIST), Dr Aiguader 88, 08003 Barcelona, Spain. Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Dr Aiguader 88, 08003 Barcelona, Spain. Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Unitat d'Oncologia Ginecològica, Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Borràs E, Sabidó E] Centre de Regulació Genòmica, Barcelona Institute of Science and Technology (BIST), Dr Aiguader 88, 08003 Barcelona, Spain. Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Dr Aiguader 88, 08003 Barcelona, Spain. [Pérez-Benavente A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Unitat d'Oncologia Ginecològica, Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Gil-Moreno A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Unitat d'Oncologia Ginecològica, Servei de Ginecologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red (CIBERONC), Instituto de Salud Carlos III, Avenida de Monforte de Lemos 3-5, 28029 Madrid, Spain. [Santamaria A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Laboratori de Cicle Cel·lular i Càncer, Grup de Recerca Biomèdica en Urologia, Vall Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
0301 basic medicine ,Oncology ,Proteomics ,Cancer Research ,medicine.medical_specialty ,Ovaris - Càncer -Tractament ,medicine.medical_treatment ,Genomics ,Disease ,Review ,Proteòmica ,neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias ováricas [ENFERMEDADES] ,Ovaris -- Càncer ,Mini review ,03 medical and health sciences ,0302 clinical medicine ,proteomics ,Natural Science Disciplines::Biological Science Disciplines::Biochemistry::Proteomics [DISCIPLINES AND OCCUPATIONS] ,Ovarian cancer ,Internal medicine ,medicine ,Serous ovarian cancer ,genomics ,RC254-282 ,Otros calificadores::/terapia [Otros calificadores] ,mass spectrometry ,Chemotherapy ,Mass spectrometry ,business.industry ,Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Ovarian Neoplasms [DISEASES] ,disciplinas de las ciencias naturales::disciplinas de las ciencias biológicas::bioquímica::proteómica [DISCIPLINAS Y OCUPACIONES] ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Biomarker ,Other subheadings::/therapy [Other subheadings] ,medicine.disease ,030104 developmental biology ,ovarian cancer ,030220 oncology & carcinogenesis ,Biomarker (medicine) ,biomarker ,business ,Cancer tissue ,cancer tissue - Abstract
Teixit cancerígen; Càncer d'ovaris; Proteòmica Tejido canceroso; Cáncer de ovarios; Proteómica Cancer tissue; Ovarian cancer; Proteomics High-grade serous ovarian cancer (HGSC) remains the most common and deadly subtype of ovarian cancer. It is characterized by its late diagnosis and frequent relapse despite standardized treatment with cytoreductive surgery and platinum-based chemotherapy. The past decade has seen significant advances in the clinical management and molecular understanding of HGSC following the publication of the Cancer Genome Atlas (TCGA) researchers and the introduction of targeted therapies with anti-angiogenic drugs and poly(ADP-ribose) polymerase inhibitors in specific subgroups of patients. We provide a comprehensive review of HGSC, focusing on the most important molecular advances aimed at providing a better understanding of the disease and its response to treatment. We emphasize the role that proteomic technologies are now playing in these two aspects of the disease, through the identification of proteins and their post-translational modifications in ovarian cancer tumors. Finally, we highlight how the integration of proteomics with genomics, exemplified by the work performed by the Clinical Proteomic Tumor Analysis Consortium (CPTAC), can guide the development of new biomarkers and therapeutic targets. This work was supported by the PhD4MD collaborative research program between the Vall d’Hebron Research Institute (VHIR) and the Centre for Genomic Regulation (CRG). The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17/0019 of the PE I + D + i 2013–2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF. We acknowledge support from the Spanish Ministry of Science and Innovation (CTQ2016-80364-P) and “Centro de Excelencia Severo Ochoa 2013–2017”, SEV-2012-0208; the “Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya” (2017SGR595 and 2017SGR1661), from the Instituto de Salud Carlos III (PI15/02238, PI18/01017, CPII18/00027) and from the Ministerio de Economia y Competitividad y Fondos FEDER (RTC-2015-3821). We also acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya.
- Published
- 2021
26. Theoretical Assessment of Indistinguishable Peptides in Mass Spectrometry-Based Proteomics.
- Author
-
Elhamraoui Z, Borràs E, Wilhelm M, and Sabidó E
- Subjects
- Humans, Proteome analysis, Proteomics methods, Peptides analysis, Peptides chemistry, Mass Spectrometry methods
- Abstract
Mass-spectrometry-based proteomics has advanced with the integration of experimental and predicted spectral libraries, which have significantly improved peptide identification in complex search spaces. However, challenges persist in distinguishing some peptides with close retention times and nearly identical fragmentation patterns. In this study, we conducted a theoretical assessment to quantify the prevalence of indistinguishable peptides within the human canonical proteome and immunopeptidome using state-of-the-art retention time and spectrum prediction models. By quantifying the proportion of peptides posing challenges to unequivocal identification, we set the theoretical nonaccessible portion within a given proteome, and underscore the effectiveness of contemporary analytical methodologies in resolving the complexity of the human proteome and immunopeptidome via mass spectrometry.
- Published
- 2024
- Full Text
- View/download PDF
27. Spectral libraries from nucleobases and deoxyribonucleosides facilitate the identification of ribonucleosides by nano-flow liquid chromatography-tandem mass spectrometry.
- Author
-
Espadas G, Llovera L, Ollivier A, Tuorto F, Novoa EM, and Sabidó E
- Subjects
- Chromatography, High Pressure Liquid methods, Nanotechnology methods, Chromatography, Liquid methods, Tandem Mass Spectrometry methods, Ribonucleosides chemistry, Ribonucleosides analysis, Deoxyribonucleosides chemistry
- Abstract
Rationale: The study addresses the challenge of identifying RNA post-transcriptional modifications when commercial standards are not available to generate reference spectral libraries. It proposes employing homologous nucleobases and deoxyribonucleosides as alternative reference spectral libraries to aid in identifying modified ribonucleosides and distinguishing them from their positional isomers when the standards are unavailable., Methods: Complete sets of ribonucleoside, deoxyribonucleoside and nucleobase standards were analyzed using high-performance nano-flow liquid chromatography coupled to an Orbitrap Eclipse Tribrid mass spectrometer. Spectral libraries were constructed from homologous nucleobases and deoxyribonucleosides using targeted MS2 and neutral-loss-triggered MS3 methods, and collision energies were optimized. The feasibility of using these libraries for identifying modified ribonucleosides and their positional isomers was assessed through comparison of spectral fragmentation patterns., Results: Our analysis reveals that both MS2 and neutral-loss-triggered MS3 methods yielded rich spectra with similar fragmentation patterns across ribonucleosides, deoxyribonucleosides and nucleobases. Moreover, we demonstrate that spectra from nucleobases and deoxyribonucleosides, generated at optimized collision energies, exhibited sufficient similarity to those of modified ribonucleosides to enable their use as reference spectra for accurate identification of positional isomers within ribonucleoside families., Conclusions: The study demonstrates the efficacy of utilizing homologous nucleobases and deoxyribonucleosides as interchangeable reference spectral libraries for identifying modified ribonucleosides and their positional isomers. This approach offers a valuable solution for overcoming limitations posed by the unavailability of commercial standards, enhancing the analysis of RNA post-transcriptional modifications via mass spectrometry., (© 2024 The Authors. Rapid Communications in Mass Spectrometry published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
28. Quantitative proteome analysis of LAP1-deficient human fibroblasts: A pilot approach for predicting the signaling pathways deregulated in LAP1-associated diseases.
- Author
-
Pereira CD, Espadas G, Martins F, Bertrand AT, Servais L, Sabidó E, Chevalier P, da Cruz E Silva OAB, and Rebelo S
- Abstract
Lamina-associated polypeptide 1 (LAP1), a ubiquitously expressed nuclear envelope protein, appears to be essential for the maintenance of cell homeostasis. Although rare, mutations in the human LAP1-encoding TOR1AIP1 gene cause severe diseases and can culminate in the premature death of affected individuals. Despite there is increasing evidence of the pathogenicity of TOR1AIP1 mutations, the current knowledge on LAP1's physiological roles in humans is limited; hence, investigation is required to elucidate the critical functions of this protein, which can be achieved by uncovering the molecular consequences of LAP1 depletion, a topic that remains largely unexplored. In this work, the proteome of patient-derived LAP1-deficient fibroblasts carrying a pathological TOR1AIP1 mutation (LAP1 E482A) was quantitatively analyzed to identify global changes in protein abundance levels relatively to control fibroblasts. An in silico functional enrichment analysis of the mass spectrometry-identified differentially expressed proteins was also performed, along with additional in vitro functional assays, to unveil the biological processes that are potentially dysfunctional in LAP1 E482A fibroblasts. Collectively, our findings suggest that LAP1 deficiency may induce significant alterations in various cellular activities, including DNA repair, messenger RNA degradation/translation, proteostasis and glutathione metabolism/antioxidant response. This study sheds light on possible new functions of human LAP1 and could set the basis for subsequent in-depth mechanistic investigations. Moreover, by identifying deregulated signaling pathways in LAP1-deficient cells, our work may offer valuable molecular targets for future disease-modifying therapies for TOR1AIP1 -associated nuclear envelopathies., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
29. Machine learning-based health environmental-clinical risk scores in European children.
- Author
-
Guimbaud JB, Siskos AP, Sakhi AK, Heude B, Sabidó E, Borràs E, Keun H, Wright J, Julvez J, Urquiza J, Gützkow KB, Chatzi L, Casas M, Bustamante M, Nieuwenhuijsen M, Vrijheid M, López-Vicente M, de Castro Pascual M, Stratakis N, Robinson O, Grazuleviciene R, Slama R, Alemany S, Basagaña X, Plantevit M, Cazabet R, and Maitre L
- Abstract
Background: Early life environmental stressors play an important role in the development of multiple chronic disorders. Previous studies that used environmental risk scores (ERS) to assess the cumulative impact of environmental exposures on health are limited by the diversity of exposures included, especially for early life determinants. We used machine learning methods to build early life exposome risk scores for three health outcomes using environmental, molecular, and clinical data., Methods: In this study, we analyzed data from 1622 mother-child pairs from the HELIX European birth cohorts, using over 300 environmental, 100 child peripheral, and 18 mother-child clinical markers to compute environmental-clinical risk scores (ECRS) for child behavioral difficulties, metabolic syndrome, and lung function. ECRS were computed using LASSO, Random Forest and XGBoost. XGBoost ECRS were selected to extract local feature contributions using Shapley values and derive feature importance and interactions., Results: ECRS captured 13%, 50% and 4% of the variance in mental, cardiometabolic, and respiratory health, respectively. We observed no significant differences in predictive performances between the above-mentioned methods.The most important predictive features were maternal stress, noise, and lifestyle exposures for mental health; proteome (mainly IL1B) and metabolome features for cardiometabolic health; child BMI and urine metabolites for respiratory health., Conclusions: Besides their usefulness for epidemiological research, our risk scores show great potential to capture holistic individual level non-hereditary risk associations that can inform practitioners about actionable factors of high-risk children. As in the post-genetic era personalized prevention medicine will focus more and more on modifiable factors, we believe that such integrative approaches will be instrumental in shaping future healthcare paradigms., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
30. IκB kinase-α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage-based anticancer therapy.
- Author
-
Pecharromán I, Solé L, Álvarez-Villanueva D, Lobo-Jarne T, Alonso-Marañón J, Bertran J, Guillén Y, Montoto Á, Martínez-Iniesta M, García-Hernández V, Giménez G, Salazar R, Santos C, Garrido M, Borràs E, Sabidó E, Bonfill-Teixidor E, Iurlaro R, Seoane J, Villanueva A, Iglesias M, Bigas A, and Espinosa L
- Subjects
- Humans, NF-kappa B metabolism, Nuclear Proteins genetics, Nuclear Proteins metabolism, Protein Serine-Threonine Kinases metabolism, Janus Kinases genetics, STAT Transcription Factors, Phosphorylation, Tumor Necrosis Factor-alpha metabolism, Transcription Factors genetics, Transcription Factors metabolism, Cell Cycle Proteins genetics, Cell Cycle Proteins metabolism, I-kappa B Kinase metabolism, Signal Transduction
- Abstract
Activation of the IκB kinase (IKK) complex has recurrently been linked to colorectal cancer (CRC) initiation and progression. However, identification of downstream effectors other than NF-κB has remained elusive. Here, analysis of IKK-dependent substrates in CRC cells after UV treatment revealed that phosphorylation of BRD4 by IKK-α is required for its chromatin-binding at target genes upon DNA damage. Moreover, IKK-α induces the NF-κB-dependent transcription of the cytokine LIF, leading to STAT3 activation, association with BRD4 and recruitment to specific target genes. IKK-α abrogation results in defective BRD4 and STAT3 functions and consequently irreparable DNA damage and apoptotic cell death upon different stimuli. Simultaneous inhibition of BRAF-dependent IKK-α activity, BRD4, and the JAK/STAT pathway enhanced the therapeutic potential of 5-fluorouracil combined with irinotecan in CRC cells and is curative in a chemotherapy-resistant xenograft model. Finally, coordinated expression of LIF and IKK-α is a poor prognosis marker for CRC patients. Our data uncover a functional link between IKK-α, BRD4, and JAK/STAT signaling with clinical relevance., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
31. Stepwise emergence of the neuronal gene expression program in early animal evolution.
- Author
-
Najle SR, Grau-Bové X, Elek A, Navarrete C, Cianferoni D, Chiva C, Cañas-Armenteros D, Mallabiabarrena A, Kamm K, Sabidó E, Gruber-Vodicka H, Schierwater B, Serrano L, and Sebé-Pedrós A
- Subjects
- Animals, Ctenophora genetics, Gene Expression, Phylogeny, Single-Cell Analysis, Paracrine Communication, Biological Evolution, Neurons physiology, Invertebrates cytology, Invertebrates genetics, Invertebrates metabolism
- Abstract
The assembly of the neuronal and other major cell type programs occurred early in animal evolution. We can reconstruct this process by studying non-bilaterians like placozoans. These small disc-shaped animals not only have nine morphologically described cell types and no neurons but also show coordinated behaviors triggered by peptide-secreting cells. We investigated possible neuronal affinities of these peptidergic cells using phylogenetics, chromatin profiling, and comparative single-cell genomics in four placozoans. We found conserved cell type expression programs across placozoans, including populations of transdifferentiating and cycling cells, suggestive of active cell type homeostasis. We also uncovered fourteen peptidergic cell types expressing neuronal-associated components like the pre-synaptic scaffold that derive from progenitor cells with neurogenesis signatures. In contrast, earlier-branching animals like sponges and ctenophores lacked this conserved expression. Our findings indicate that key neuronal developmental and effector gene modules evolved before the advent of cnidarian/bilaterian neurons in the context of paracrine cell signaling., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
32. Assessment and Prediction of Human Proteotypic Peptide Stability for Proteomics Quantification.
- Author
-
Chiva C, Elhamraoui Z, Solé A, Serret M, Wilhelm M, and Sabidó E
- Subjects
- Humans, Peptides, Chromatography, Liquid, Mass Spectrometry, Proteome, Proteomics
- Abstract
Mass spectrometry coupled to liquid chromatography is one of the most powerful technologies for proteome quantification in biomedical samples. In peptide-centric workflows, protein mixtures are enzymatically digested to peptides prior their analysis. However, proteome-wide quantification studies rarely identify all potential peptides for any given protein, and targeted proteomics experiments focus on a set of peptides for the proteins of interest. Consequently, proteomics relies on the use of a limited subset of all possible peptides as proxies for protein quantitation. In this work, we evaluated the stability of the human proteotypic peptides during 21 days and trained a deep learning model to predict peptide stability directly from tryptic sequences, which together constitute a resource of broad interest to prioritize and select peptides in proteome quantification experiments.
- Published
- 2023
- Full Text
- View/download PDF
33. Expression of NORAD correlates with breast cancer aggressiveness and protects breast cancer cells from chemotherapy.
- Author
-
Alves-Vale C, Capela AM, Tavares-Marcos C, Domingues-Silva B, Pereira B, Santos F, Gomes CP, Espadas G, Vitorino R, Sabidó E, Borralho P, Nóbrega-Pereira S, and Bernardes de Jesus B
- Abstract
The recently discovered human lncRNA NORAD is induced after DNA damage in a p53-dependent manner. It plays a critical role in the maintenance of genomic stability through interaction with Pumilio proteins, limiting the repression of their target mRNAs. Therefore, NORAD inactivation causes chromosomal instability and aneuploidy, which contributes to the accumulation of genetic abnormalities and tumorigenesis. NORAD has been detected in several types of cancer, including breast cancer, which is the most frequently diagnosed and the second-leading cause of cancer death in women. In the present study, we confirmed upregulated NORAD expression levels in a set of human epithelial breast cancer cell lines (MDA-MB-231, MDA-MB-436, and MDA-MB-468), which belong to the most aggressive subtypes (triple-negative breast cancer). These results are in line with previous data showing that high NORAD expression levels in basal-like tumors were associated with poor prognosis. Here, we demonstrate that NORAD downregulation sensitizes triple-negative breast cancer cells to chemotherapy, through a potential accumulation of genomic aberrations and an impaired capacity to signal DNA damage. These results show that NORAD may represent an unexploited neoadjuvant therapeutic target for chemotherapy-unresponsive breast cancer., Competing Interests: The authors declare no competing interests., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
34. Beauveria bassiana rewires molecular mechanisms related to growth and defense in tomato.
- Author
-
Proietti S, Falconieri GS, Bertini L, Pascale A, Bizzarri E, Morales-Sanfrutos J, Sabidó E, Ruocco M, Monti MM, Russo A, Dziurka K, Ceci M, Loreto F, and Caruso C
- Subjects
- Botrytis physiology, Plant Development, Plants, Plant Leaves metabolism, Proteome, Symbiosis, Beauveria physiology, Plant Diseases microbiology, Solanum lycopersicum genetics, Solanum lycopersicum microbiology, Solanum lycopersicum physiology
- Abstract
Plant roots can exploit beneficial associations with soil-inhabiting microbes, promoting growth and expanding the immune capacity of the host plant. In this work, we aimed to provide new information on changes occurring in tomato interacting with the beneficial fungus Beauveria bassiana. The tomato leaf proteome revealed perturbed molecular pathways during the establishment of the plant-fungus relationship. In the early stages of colonization (5-7 d), proteins related to defense responses to the fungus were down-regulated and proteins related to calcium transport were up-regulated. At later time points (12-19 d after colonization), up-regulation of molecular pathways linked to protein/amino acid turnover and to biosynthesis of energy compounds suggests beneficial interaction enhancing plant growth and development. At the later stage, the profile of leaf hormones and related compounds was also investigated, highlighting up-regulation of those related to plant growth and defense. Finally, B. bassiana colonization was found to improve plant resistance to Botrytis cinerea, impacting plant oxidative damage. Overall, our findings further expand current knowledge on the possible mechanisms underlying the beneficial role of B. bassiana in tomato plants., (© The Author(s) 2023. Published by Oxford University Press on behalf of the Society for Experimental Biology.)
- Published
- 2023
- Full Text
- View/download PDF
35. Thymine DNA glycosylase regulates cell-cycle-driven p53 transcriptional control in pluripotent cells.
- Author
-
Aranda S, Alcaine-Colet A, Ballaré C, Blanco E, Mocavini I, Sparavier A, Vizán P, Borràs E, Sabidó E, and Di Croce L
- Subjects
- Animals, Mice, Cell Cycle genetics, Cell Line, Gene Expression Regulation, Thymine DNA Glycosylase genetics, Thymine DNA Glycosylase metabolism, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 metabolism
- Abstract
Cell cycle progression is linked to transcriptome dynamics and variations in the response of pluripotent cells to differentiation cues, mostly through unknown determinants. Here, we characterized the cell-cycle-associated transcriptome and proteome of mouse embryonic stem cells (mESCs) in naive ground state. We found that the thymine DNA glycosylase (TDG) is a cell-cycle-regulated co-factor of the tumor suppressor p53. Furthermore, TDG and p53 co-bind ESC-specific cis-regulatory elements and thereby control transcription of p53-dependent genes during self-renewal. We determined that the dynamic expression of TDG is required to promote the cell-cycle-associated transcriptional heterogeneity. Moreover, we demonstrated that transient depletion of TDG influences cell fate decisions during the early differentiation of mESCs. Our findings reveal an unanticipated role of TDG in promoting molecular heterogeneity during the cell cycle and highlight the central role of protein dynamics for the temporal control of cell fate during development., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
36. Molecular signature associated with cladribine treatment in patients with multiple sclerosis.
- Author
-
Fissolo N, Calvo-Barreiro L, Eixarch H, Boschert U, Villar LM, Costa-Frossard L, Ferrer M, Sanchez A, Borràs E, Sabidó E, Espejo C, Montalban X, and Comabella M
- Subjects
- Humans, Cladribine pharmacology, Cladribine therapeutic use, Leukocytes, Mononuclear metabolism, Proteomics, Biomarkers, Multiple Sclerosis drug therapy, Multiple Sclerosis genetics, Multiple Sclerosis metabolism, MicroRNAs metabolism
- Abstract
Introduction: Little is known about the molecular profiling associated with the effect of cladribine in patients with multiple sclerosis (MS). Here, we aimed first to characterize the transcriptomic and proteomic profiles induced by cladribine in blood cells, and second to identify potential treatment response biomarkers to cladribine in patients with MS., Methods: Gene, protein and microRNA (miRNA) expression profiles were determined by microarrays (genes, miRNAs) and mass spectrometry (proteins) in peripheral blood mononuclear cells (PBMCs) from MS patients after in vitro treatment with cladribine in its active and inactive forms. Two bioinformatics approaches to integrate the three obtained datasets were applied: (i) a multiomics discriminant analysis (DIABLO - Data Integration Analysis for Biomarker discovery using Latent variable approaches for Omics studies); and (ii) a multi-stage integration of features selected in differential expression analysis on each dataset and then merged. Selected molecules from the in vitro study were quantified by qPCR ex vivo in PBMCs from MS patients receiving cladribine., Results: PBMCs treated in vitro with cladribine were characterized by a major downregulation of gene, protein, and miRNA expression compared with the untreated cells. An intermediate pattern between the cladribine-treated and untreated conditions was observed in PBMCs treated with cladribine in its inactive form. The differential expression analysis of each dataset led to the identification of four genes and their encoded proteins, and twenty-two miRNAs regulating their expression, that were associated with cladribine treatment. Two of these genes (PPIF and NHLRC2), and three miRNAs (miR-21-5p, miR-30b-5p, and miR-30e-5p) were validated ex vivo in MS patients treated with cladribine., Discussion: By using a combination of omics data and bioinformatics approaches we were able to identify a multiomics molecular profile induced by cladribine in vitro in PBMCs. We also identified a number of biomarkers that were validated ex vivo in PBMCs from patients with MS treated with cladribine that have the potential to become treatment response biomarkers to this drug., Competing Interests: UB is an employee of Ares Trading SA, Eysins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Fissolo, Calvo-Barreiro, Eixarch, Boschert, Villar, Costa-Frossard, Ferrer, Sanchez, Borràs, Sabidó, Espejo, Montalban and Comabella.)
- Published
- 2023
- Full Text
- View/download PDF
37. Updated MS²PIP web server supports cutting-edge proteomics applications.
- Author
-
Declercq A, Bouwmeester R, Chiva C, Sabidó E, Hirschler A, Carapito C, Martens L, Degroeve S, and Gabriels R
- Subjects
- Tandem Mass Spectrometry, Peptides chemistry, Proteomics, Proteome
- Abstract
Interest in the use of machine learning for peptide fragmentation spectrum prediction has been strongly on the rise over the past years, especially for applications in challenging proteomics identification workflows such as immunopeptidomics and the full-proteome identification of data independent acquisition spectra. Since its inception, the MS²PIP peptide spectrum predictor has been widely used for various downstream applications, mostly thanks to its accuracy, ease-of-use, and broad applicability. We here present a thoroughly updated version of the MS²PIP web server, which includes new and more performant prediction models for both tryptic- and non-tryptic peptides, for immunopeptides, and for CID-fragmented TMT-labeled peptides. Additionally, we have also added new functionality to greatly facilitate the generation of proteome-wide predicted spectral libraries, requiring only a FASTA protein file as input. These libraries also include retention time predictions from DeepLC. Moreover, we now provide pre-built and ready-to-download spectral libraries for various model organisms in multiple DIA-compatible spectral library formats. Besides upgrading the back-end models, the user experience on the MS²PIP web server is thus also greatly enhanced, extending its applicability to new domains, including immunopeptidomics and MS3-based TMT quantification experiments. MS²PIP is freely available at https://iomics.ugent.be/ms2pip/., (© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2023
- Full Text
- View/download PDF
38. Dynamic interplay between RPL3- and RPL3L-containing ribosomes modulates mitochondrial activity in the mammalian heart.
- Author
-
Milenkovic I, Santos Vieira HG, Lucas MC, Ruiz-Orera J, Patone G, Kesteven S, Wu J, Feneley M, Espadas G, Sabidó E, Hübner N, van Heesch S, Völkers M, and Novoa EM
- Subjects
- Animals, Mice, Muscle, Skeletal metabolism, Protein Biosynthesis, Heart, Mitochondria metabolism, Ribosomal Proteins genetics, Ribosomal Proteins metabolism, Ribosomes genetics, Ribosomes metabolism
- Abstract
The existence of naturally occurring ribosome heterogeneity is now a well-acknowledged phenomenon. However, whether this heterogeneity leads to functionally diverse 'specialized ribosomes' is still a controversial topic. Here, we explore the biological function of RPL3L (uL3L), a ribosomal protein (RP) paralogue of RPL3 (uL3) that is exclusively expressed in skeletal muscle and heart tissues, by generating a viable homozygous Rpl3l knockout mouse strain. We identify a rescue mechanism in which, upon RPL3L depletion, RPL3 becomes up-regulated, yielding RPL3-containing ribosomes instead of RPL3L-containing ribosomes that are typically found in cardiomyocytes. Using both ribosome profiling (Ribo-seq) and a novel orthogonal approach consisting of ribosome pulldown coupled to nanopore sequencing (Nano-TRAP), we find that RPL3L modulates neither translational efficiency nor ribosome affinity towards a specific subset of transcripts. In contrast, we show that depletion of RPL3L leads to increased ribosome-mitochondria interactions in cardiomyocytes, which is accompanied by a significant increase in ATP levels, potentially as a result of fine-tuning of mitochondrial activity. Our results demonstrate that the existence of tissue-specific RP paralogues does not necessarily lead to enhanced translation of specific transcripts or modulation of translational output. Instead, we reveal a complex cellular scenario in which RPL3L modulates the expression of RPL3, which in turn affects ribosomal subcellular localization and, ultimately, mitochondrial activity., (© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2023
- Full Text
- View/download PDF
39. New Ruthenium-Cyclopentadienyl Complexes Affect Colorectal Cancer Hallmarks Showing High Therapeutic Potential.
- Author
-
Brás AR, Fernandes P, Moreira T, Morales-Sanfrutos J, Sabidó E, Antunes AMM, Valente A, and Preto A
- Abstract
Colorectal cancer (CRC) is among the most deadly cancers worldwide. Current therapeutic strategies have low success rates and several side effects. This relevant clinical problem requires the discovery of new and more effective therapeutic alternatives. Ruthenium drugs have arisen as one of the most promising metallodrugs, due to their high selectivity to cancer cells. In this work we studied, for the first time, the anticancer properties and mechanisms of action of four lead Ru-cyclopentadienyl compounds, namely PMC79 , PMC78 , LCR134 and LCR220 , in two CRC-derived cell lines (SW480 and RKO). Biological assays were performed on these CRC cell lines to evaluate cellular distribution, colony formation, cell cycle, proliferation, apoptosis, and motility, as well as cytoskeleton and mitochondrial alterations. Our results show that all the compounds displayed high bioactivity and selectivity, as shown by low half-maximal inhibitory concentrations (IC
50 ) against CRC cells. We observed that all the Ru compounds have different intracellular distributions. In addition, they inhibit to a high extent the proliferation of CRC cells by decreasing clonogenic ability and inducing cell cycle arrest. PMC79 , LCR134 , and LCR220 also induce apoptosis, increase the levels of reactive oxygen species, lead to mitochondrial dysfunction, induce actin cytoskeleton alterations, and inhibit cellular motility. A proteomic study revealed that these compounds cause modifications in several cellular proteins associated with the phenotypic alterations observed. Overall, we demonstrate that Ru compounds, especially PMC79 and LCR220 , display promising anticancer activity in CRC cells with a high potential to be used as new metallodrugs for CRC therapy.- Published
- 2023
- Full Text
- View/download PDF
40. Childhood exposure to non-persistent endocrine disrupting chemicals and multi-omic profiles: A panel study.
- Author
-
Fabbri L, Garlantézec R, Audouze K, Bustamante M, Carracedo Á, Chatzi L, Ramón González J, Gražulevičienė R, Keun H, Lau CE, Sabidó E, Siskos AP, Slama R, Thomsen C, Wright J, Lun Yuan W, Casas M, Vrijheid M, and Maitre L
- Subjects
- Child, Humans, Leptin, Kynurenine, Multiomics, Serotonin, Endocrine Disruptors adverse effects, Triclosan, Environmental Pollutants
- Abstract
Background: Individuals are exposed to environmental pollutants with endocrine disrupting activity (endocrine disruptors, EDCs) and the early stages of life are particularly susceptible to these exposures. Previous studies have focused on identifying molecular signatures associated with EDCs, but none have used repeated sampling strategy and integrated multiple omics. We aimed to identify multi-omic signatures associated with childhood exposure to non-persistent EDCs., Methods: We used data from the HELIX Child Panel Study, which included 156 children aged 6 to 11. Children were followed for one week, in two time periods. Twenty-two non-persistent EDCs (10 phthalate, 7 phenol, and 5 organophosphate pesticide metabolites) were measured in two weekly pools of 15 urine samples each. Multi-omic profiles (methylome, serum and urinary metabolome, proteome) were measured in blood and in a pool urine samples. We developed visit-specific Gaussian Graphical Models based on pairwise partial correlations. The visit-specific networks were then merged to identify reproducible associations. Independent biological evidence was systematically sought to confirm some of these associations and assess their potential health implications., Results: 950 reproducible associations were found among which 23 were direct associations between EDCs and omics. For 9 of them, we were able to find corroborating evidence from previous literature: DEP - serotonin, OXBE - cg27466129, OXBE - dimethylamine, triclosan - leptin, triclosan - serotonin, MBzP - Neu5AC, MEHP - cg20080548, oh-MiNP - kynurenine, oxo-MiNP - 5-oxoproline. We used these associations to explore possible mechanisms between EDCs and health outcomes, and found links to health outcomes for 3 analytes: serotonin and kynurenine in relation to neuro-behavioural development, and leptin in relation to obesity and insulin resistance., Conclusions: This multi-omics network analysis at two time points identified biologically relevant molecular signatures related to non-persistent EDC exposure in childhood, suggesting pathways related to neurological and metabolic outcomes., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
41. Loss of dyskerin facilitates the acquisition of metastatic traits by altering the mevalonate pathway.
- Author
-
Andrades E, Toll A, Deza G, Segura S, Gimeno R, Espadas G, Sabidó E, Haro N, Pozo ÓJ, Bódalo M, Torres P, Pujol RM, and Hernández-Muñoz I
- Subjects
- Humans, Mevalonic Acid, Phenotype, Simvastatin pharmacology, Nuclear Proteins, Cell Cycle Proteins, Carcinoma, Squamous Cell metabolism, Skin Neoplasms pathology
- Abstract
The initial dissemination of cancer cells from many primary tumors implies intravasation to lymphatic nodes or blood vessels. To investigate the mechanisms involved, we analyzed the expression of small non-coding RNAs in cutaneous squamous cell carcinoma (cSCC), a prevalent tumor that mainly spreads to lymph nodes. We report the reduced expression of small nucleolar RNAs in primary cSCCs that metastasized when compared to non-metastasizing cSCCs, and the progressive loss of DKC1 (dyskerin, which stabilizes the small nucleolar RNAs) along the metastasis. DKC1 depletion in cSCC cells triggered lipid metabolism by altering the mevalonate pathway and the acquisition of metastatic traits. Treatment of DKC1-depleted cells with simvastatin, an inhibitor of the mevalonate pathway, blocked the expression of proteins involved in the epithelial-to-mesenchymal transition. Consistently, the expression of the enzyme 3-hydroxy-3-methylglutaryl-CoA synthase 1 was associated with pathological features of high metastatic risk in cSCC patients. Our data underpin the relevance of the mevalonate metabolism in metastatic dissemination and pave the possible incorporation of therapeutic approaches among the antineoplastic drugs used in routine patient care., (© 2023 Andrades et al.)
- Published
- 2023
- Full Text
- View/download PDF
42. Peptidomics Methods Applied to the Study of Flower Development.
- Author
-
Álvarez-Urdiola R, Borràs E, Valverde F, Matus JT, Sabidó E, and Riechmann JL
- Subjects
- Chromatography, Liquid methods, Peptides chemistry, Proteome chemistry, Flowers, Proteomics methods, Tandem Mass Spectrometry methods
- Abstract
Understanding the global and dynamic nature of plant developmental processes requires not only the study of the transcriptome, but also of the proteome, including its largely uncharacterized peptidome fraction. Recent advances in proteomics and high-throughput analyses of translating RNAs (ribosome profiling) have begun to address this issue, evidencing the existence of novel, uncharacterized, and possibly functional peptides. To validate the accumulation in tissues of sORF-encoded polypeptides (SEPs), the basic setup of proteomic analyses (i.e., LC-MS/MS) can be followed. However, the detection of peptides that are small (up to ~100 aa, 6-7 kDa) and novel (i.e., not annotated in reference databases) presents specific challenges that need to be addressed both experimentally and with computational biology resources. Several methods have been developed in recent years to isolate and identify peptides from plant tissues. In this chapter, we outline two different peptide extraction protocols and the subsequent peptide identification by mass spectrometry using the database search or the de novo identification methods., (© 2023. Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
43. A combination of molecular and clinical parameters provides a new strategy for high-grade serous ovarian cancer patient management.
- Author
-
Bradbury M, Borràs E, Vilar M, Castellví J, Sánchez-Iglesias JL, Pérez-Benavente A, Gil-Moreno A, Santamaria A, and Sabidó E
- Subjects
- Humans, Female, Proteomics methods, Proteins therapeutic use, Biomarkers, Tumor metabolism, Cystadenocarcinoma, Serous diagnosis, Cystadenocarcinoma, Serous drug therapy, Cystadenocarcinoma, Serous genetics, Ovarian Neoplasms drug therapy
- Abstract
Background: High-grade serous carcinoma (HGSC) is the most common and deadly subtype of ovarian cancer. Although most patients will initially respond to first-line treatment with a combination of surgery and platinum-based chemotherapy, up to a quarter will be resistant to treatment. We aimed to identify a new strategy to improve HGSC patient management at the time of cancer diagnosis (HGSC-1LTR)., Methods: A total of 109 ready-available formalin-fixed paraffin-embedded HGSC tissues obtained at the time of HGSC diagnosis were selected for proteomic analysis. Clinical data, treatment approach and outcomes were collected for all patients. An initial discovery cohort (n = 21) were divided into chemoresistant and chemosensitive groups and evaluated using discovery mass-spectrometry (MS)-based proteomics. Proteins showing differential abundance between groups were verified in a verification cohort (n = 88) using targeted MS-based proteomics. A logistic regression model was used to select those proteins able to correctly classify patients into chemoresistant and chemosensitive. The classification performance of the protein and clinical data combinations were assessed through the generation of receiver operating characteristic (ROC) curves., Results: Using the HGSC-1LTR strategy we have identified a molecular signature (TKT, LAMC1 and FUCO) that combined with ready available clinical data (patients' age, menopausal status, serum CA125 levels, and treatment approach) is able to predict patient response to first-line treatment with an AUC: 0.82 (95% CI 0.72-0.92)., Conclusions: We have established a new strategy that combines molecular and clinical parameters to predict the response to first-line treatment in HGSC patients (HGSC-1LTR). This strategy can allow the identification of chemoresistance at the time of diagnosis providing the optimization of therapeutic decision making and the evaluation of alternative treatment strategies. Thus, advancing towards the improvement of patient outcome and the individualization of HGSC patients' care., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
44. Proteomic profiling reveals mitochondrial dysfunction in the cerebellum of transgenic mice overexpressing DYRK1A, a Down syndrome candidate gene.
- Author
-
Ortega M, De Toma I, Fernández-Blanco Á, Calderón A, Barahona L, Trullàs R, Sabidó E, and Dierssen M
- Abstract
Introduction: DYRK1A is a dual-specificity kinase that is overexpressed in Down syndrome (DS) and plays a key role in neurogenesis, neuronal differentiation and function, cognitive phenotypes, and aging. Dyrk1A has also been implicated in cerebellar abnormalities observed in association with DS, and normalization of Dyrk1A dosage rescues granular and Purkinje cell densities in a trisomic DS mouse model. However, the underlying molecular mechanisms governing these processes are unknown., Methods: To shed light on the effects of Dyrk1A overexpression in the cerebellum, here we investigated the cerebellar proteome in transgenic Dyrk1A overexpressing mice in basal conditions and after treatment with green tea extract containing epigallocatechin-3-gallate (EGCG), a DYRK1A inhibitor., Results and Discussion: Our results showed that Dyrk1A overexpression alters oxidative phosphorylation and mitochondrial function in the cerebellum of transgenic mice. These alterations are significantly rescued upon EGCG-containing green tea extract treatment, suggesting that its effects in DS could depend in part on targeting mitochondria, as shown by the partially restoration by the treatment of the increased mtDNA copy number in TG non-treated mice., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 De Toma, Ortega, Fernández-Blanco, Calderón, Barahona, Trullàs, Sabidó and Dierssen.)
- Published
- 2022
- Full Text
- View/download PDF
45. Multi-omics signatures of the human early life exposome.
- Author
-
Maitre L, Bustamante M, Hernández-Ferrer C, Thiel D, Lau CE, Siskos AP, Vives-Usano M, Ruiz-Arenas C, Pelegrí-Sisó D, Robinson O, Mason D, Wright J, Cadiou S, Slama R, Heude B, Casas M, Sunyer J, Papadopoulou EZ, Gutzkow KB, Andrusaityte S, Grazuleviciene R, Vafeiadi M, Chatzi L, Sakhi AK, Thomsen C, Tamayo I, Nieuwenhuijsen M, Urquiza J, Borràs E, Sabidó E, Quintela I, Carracedo Á, Estivill X, Coen M, González JR, Keun HC, and Vrijheid M
- Subjects
- Pregnancy, Female, Humans, Environmental Exposure adverse effects, Cohort Studies, Metabolome, Transcriptome, Exposome
- Abstract
Environmental exposures during early life play a critical role in life-course health, yet the molecular phenotypes underlying environmental effects on health are poorly understood. In the Human Early Life Exposome (HELIX) project, a multi-centre cohort of 1301 mother-child pairs, we associate individual exposomes consisting of >100 chemical, outdoor, social and lifestyle exposures assessed in pregnancy and childhood, with multi-omics profiles (methylome, transcriptome, proteins and metabolites) in childhood. We identify 1170 associations, 249 in pregnancy and 921 in childhood, which reveal potential biological responses and sources of exposure. Pregnancy exposures, including maternal smoking, cadmium and molybdenum, are predominantly associated with child DNA methylation changes. In contrast, childhood exposures are associated with features across all omics layers, most frequently the serum metabolome, revealing signatures for diet, toxic chemical compounds, essential trace elements, and weather conditions, among others. Our comprehensive and unique resource of all associations ( https://helixomics.isglobal.org/ ) will serve to guide future investigation into the biological imprints of the early life exposome., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
46. Mass Spectrometry Identification of Biomarkers in Extracellular Vesicles From Plasmodium vivax Liver Hypnozoite Infections.
- Author
-
Gualdrón-López M, Díaz-Varela M, Zanghi G, Aparici-Herraiz I, Steel RWJ, Schäfer C, Cuscó P, Chuenchob V, Kangwangransan N, Billman ZP, Olsen TM, González JR, Roobsoong W, Sattabongkot J, Murphy SC, Mikolajczak SA, Borràs E, Sabidó E, Fernandez-Becerra C, Flannery EL, Kappe SHI, and Del Portillo HA
- Subjects
- Humans, Mice, Animals, Plasmodium vivax, Proteomics, Proteome, Filamins, Liver, Biomarkers, Mass Spectrometry, Malaria, Vivax drug therapy, Malaria, Vivax parasitology, Parasites, Extracellular Vesicles
- Abstract
Latent liver stages termed hypnozoites cause relapsing Plasmodium vivax malaria infection and represent a major obstacle in the goal of malaria elimination. Hypnozoites are clinically undetectable, and presently, there are no biomarkers of this persistent parasite reservoir in the human liver. Here, we have identified parasite and human proteins associated with extracellular vesicles (EVs) secreted from in vivo infections exclusively containing hypnozoites. We used P. vivax-infected human liver-chimeric (huHEP) FRG KO mice treated with the schizonticidal experimental drug MMV048 as hypnozoite infection model. Immunofluorescence-based quantification of P. vivax liver forms showed that MMV048 removed schizonts from chimeric mice livers. Proteomic analysis of EVs derived from FRG huHEP mice showed that human EV cargo from infected FRG huHEP mice contain inflammation markers associated with active schizont replication and identified 66 P. vivax proteins. To identify hypnozoite-specific proteins associated with EVs, we mined the proteome data from MMV048-treated mice and performed an analysis involving intragroup and intergroup comparisons across all experimental conditions followed by a peptide compatibility analysis with predicted spectra to warrant robust identification. Only one protein fulfilled this stringent top-down selection, a putative filamin domain-containing protein. This study sets the stage to unveil biological features of human liver infections and identify biomarkers of hypnozoite infection associated with EVs., Competing Interests: Conflict of interest V. C., S. A. M., and E. L. F. are employed by and/or is a shareholder of Novartis Pharma AG. Other authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
47. Transcriptome innovations in primates revealed by single-molecule long-read sequencing.
- Author
-
Ferrández-Peral L, Zhan X, Alvarez-Estape M, Chiva C, Esteller-Cucala P, García-Pérez R, Julià E, Lizano E, Fornas Ò, Sabidó E, Li Q, Marquès-Bonet T, Juan D, and Zhang G
- Subjects
- Animals, Humans, Macaca mulatta genetics, Evolution, Molecular, Primates genetics, Alternative Splicing, Protein Isoforms genetics, High-Throughput Nucleotide Sequencing methods, Transcriptome
- Abstract
Transcriptomic diversity greatly contributes to the fundamentals of disease, lineage-specific biology, and environmental adaptation. However, much of the actual isoform repertoire contributing to shaping primate evolution remains unknown. Here, we combined deep long- and short-read sequencing complemented with mass spectrometry proteomics in a panel of lymphoblastoid cell lines (LCLs) from human, three other great apes, and rhesus macaque, producing the largest full-length isoform catalog in primates to date. Around half of the captured isoforms are not annotated in their reference genomes, significantly expanding the gene models in primates. Furthermore, our comparative analyses unveil hundreds of transcriptomic innovations and isoform usage changes related to immune function and immunological disorders. The confluence of these evolutionary innovations with signals of positive selection and their limited impact in the proteome points to changes in alternative splicing in genes involved in immune response as an important target of recent regulatory divergence in primates., (© 2022 Ferrández-Peral et al.; Published by Cold Spring Harbor Laboratory Press.)
- Published
- 2022
- Full Text
- View/download PDF
48. Melanoma RBPome identification reveals PDIA6 as an unconventional RNA-binding protein involved in metastasis.
- Author
-
Mestre-Farràs N, Guerrero S, Bley N, Rivero E, Coll O, Borràs E, Sabidó E, Indacochea A, Casillas-Serra C, Järvelin AI, Oliva B, Castello A, Hüttelmaier S, and Gebauer F
- Subjects
- Cell Line, Tumor, Endoplasmic Reticulum, Humans, Molecular Chaperones genetics, Molecular Chaperones metabolism, RNA genetics, Melanoma genetics, Melanoma pathology, Neoplasm Metastasis genetics, Protein Disulfide-Isomerases genetics, Protein Disulfide-Isomerases metabolism, RNA-Binding Proteins genetics, RNA-Binding Proteins metabolism
- Abstract
RNA-binding proteins (RBPs) have been relatively overlooked in cancer research despite their contribution to virtually every cancer hallmark. Here, we use RNA interactome capture (RIC) to characterize the melanoma RBPome and uncover novel RBPs involved in melanoma progression. Comparison of RIC profiles of a non-tumoral versus a metastatic cell line revealed prevalent changes in RNA-binding capacities that were not associated with changes in RBP levels. Extensive functional validation of a selected group of 24 RBPs using five different in vitro assays unveiled unanticipated roles of RBPs in melanoma malignancy. As proof-of-principle we focused on PDIA6, an ER-lumen chaperone that displayed a novel RNA-binding activity. We show that PDIA6 is involved in metastatic progression, map its RNA-binding domain, and find that RNA binding is required for PDIA6 tumorigenic properties. These results exemplify how RIC technologies can be harnessed to uncover novel vulnerabilities of cancer cells., (© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2022
- Full Text
- View/download PDF
49. Short- and medium-term air pollution exposure, plasmatic protein levels and blood pressure in children.
- Author
-
de Prado-Bert P, Warembourg C, Dedele A, Heude B, Borràs E, Sabidó E, Aasvang GM, Lepeule J, Wright J, Urquiza J, Gützkow KB, Maitre L, Chatzi L, Casas M, Vafeiadi M, Nieuwenhuijsen MJ, de Castro M, Grazuleviciene R, McEachan RRC, Basagaña X, Vrijheid M, Sunyer J, and Bustamante M
- Subjects
- Blood Pressure, Child, Environmental Exposure adverse effects, Environmental Exposure analysis, Humans, Nitrogen Dioxide analysis, Particulate Matter analysis, Particulate Matter toxicity, Air Pollutants analysis, Air Pollutants toxicity, Air Pollution adverse effects, Air Pollution analysis
- Abstract
Exposure to air pollution influences children's health, however, the biological mechanisms underlying these effects are not completely elucidated. We investigated the association between short- and medium-term outdoor air pollution exposure with protein profiles and their link with blood pressure in 1170 HELIX children aged 6-11 years. Different air pollutants (NO
2 , PM10 , PM2.5 , and PM2.5abs ) were estimated based on residential and school addresses at three different windows of exposure (1-day, 1-week, and 1-year before clinical and molecular assessment). Thirty-six proteins, including adipokines, cytokines, or apolipoproteins, were measured in children's plasma using Luminex. Systolic and diastolic blood pressure (SBP and DBP) were measured following a standardized protocol. We performed an association study for each air pollutant at each location and time window and each outcome, adjusting for potential confounders. After correcting for multiple-testing, hepatocyte growth factor (HGF) and interleukin 8 (IL8) levels were positively associated with 1-week home exposure to some of the pollutants (NO2 , PM10 , or PM2.5 ). NO2 1-week home exposure was also related to higher SBP. The mediation study suggested that HGF could explain 19% of the short-term effect of NO2 on blood pressure, but other study designs are needed to prove the causal directionality between HGF and blood pressure., (Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
50. A phylogenetic and proteomic reconstruction of eukaryotic chromatin evolution.
- Author
-
Grau-Bové X, Navarrete C, Chiva C, Pribasnig T, Antó M, Torruella G, Galindo LJ, Lang BF, Moreira D, López-Garcia P, Ruiz-Trillo I, Schleper C, Sabidó E, and Sebé-Pedrós A
- Subjects
- Archaea genetics, DNA Transposable Elements, Eukaryota genetics, Histones genetics, Histones metabolism, Phylogeny, Proteomics, Chromatin genetics, Chromatin metabolism, Eukaryotic Cells metabolism
- Abstract
Histones and associated chromatin proteins have essential functions in eukaryotic genome organization and regulation. Despite this fundamental role in eukaryotic cell biology, we lack a phylogenetically comprehensive understanding of chromatin evolution. Here, we combine comparative proteomics and genomics analysis of chromatin in eukaryotes and archaea. Proteomics uncovers the existence of histone post-translational modifications in archaea. However, archaeal histone modifications are scarce, in contrast with the highly conserved and abundant marks we identify across eukaryotes. Phylogenetic analysis reveals that chromatin-associated catalytic functions (for example, methyltransferases) have pre-eukaryotic origins, whereas histone mark readers and chaperones are eukaryotic innovations. We show that further chromatin evolution is characterized by expansion of readers, including capture by transposable elements and viruses. Overall, our study infers detailed evolutionary history of eukaryotic chromatin: from its archaeal roots, through the emergence of nucleosome-based regulation in the eukaryotic ancestor, to the diversification of chromatin regulators and their hijacking by genomic parasites., (© 2022. The Author(s), under exclusive licence to Springer Nature Limited.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.